跳至主要内容
临床试验/NCT01256606
NCT01256606已完成不适用

Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy

Roche Sequencing Solutions6 个研究点 分布在 1 个国家目标入组 4,000 人开始时间: 2010年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
4,000
试验地点
6
主要终点
Comparison of blood test to results from chorionic villus sampling or amniocentesis for fetal aneuploidy detection

研究概览

简要总结

The purpose of this study is to develop and evaluate a blood test for pregnant women for detection of fetal aneuploidy.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Subject is 18yrs or older
  • Subject has a singleton pregnancy
  • Subject is planning to undergo chorionic villus sampling (CVS) and/or amniocentesis with current pregnancy
  • Subject is able to provide consent

排除标准

  • Subject is pregnant with more than one fetus
  • Subject (mother) has known aneuploidy
  • Subject has active malignancy requiring major surgery or systemic chemotherapy or has a history of metastatic cancer.
  • Subject has already undergone CVS or amniocentesis during current pregnancy prior to study enrollment.

结局指标

主要结局

Comparison of blood test to results from chorionic villus sampling or amniocentesis for fetal aneuploidy detection

时间窗: 24 months

Circulating genomic material from maternal blood will be quantified using biochemical techniques to determine the presence of fetal aneuploidy. The results obtained from analysis of circulating genomic material will be compared to the karyotype results from chorionic villus sampling or amniocentesis.

次要结局

未报告次要终点

研究者

发起方
Roche Sequencing Solutions
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验